Background Introduction

On March 11, the National Health Commission released the Application Scheme for COVID-19 Antigen Detection (Trial). According to the Scheme, people having symptoms within 5 days seeking medical advice from grassroots medical and health institutions, those in isolation observation, and community residents with self-testing needs can use antigen testing reagents for self-testing.

Antigen detection, with its advantages of convenience for home self-test, short time to obtain results without machine assistance, is conducive to the early diversion and rapid management of suspected populations of Covid-19. Under the severe situation of rebound of epidemic situation in many places, antigen detection can be used as a complementary means of detection. 

Qingdao Henderson Biotechnology Co., Ltd is one of the first enterprises to launch COVID-19 testing raw materials. Through continuous improvement with extensive market validation, the performance and capacity of raw materials and products have been steadily improved. 

Recommended Diagnostic Raw Materials on the Immunochromatography Platform

[Product Information]

[Product Advantages of New Craft] 

★★ The potency is higher and the dosage is small (only 1/5 of a product sold in the market)!

★ High sensitivity, the lowest detect limit of the new craft can reach 20pg/mL!

★All existing variants (including Omicron and its variants) can be detected!

★ Enough capacity, up to 100g per week!

★ Professional technical guidance to help enterprises quickly master the craft requirements!

★Be capable of offering mature products!

[Product Performance]

All the existing N protein recombinant antigens of COVID-19 mutants can be detected obviously.

[Company Background]

Qingdao Henderson Biotechnology Co., Ltd, established in 2016, serves as a professional supplier of core raw materials for in vitro diagnostic reagents and is committed to providing high-quality raw materials for global in vitro diagnostic reagent production enterprises, scientific research institutions and other fields.

The company provides the following staple products: antigens, antibodies, enzymes, etc., widely used in the detection of drug, respiratory infectious diseases (A, B, COVID-19 antigen, COVID-19 antibody, COVID-19 neutralizing antibody, syncytial virus, etc.), other infectious diseases (hepatitis, AIDS, tuberculosis, etc.), markers for tumor, inflammation, myocardial markers, animal diseases detection (dog, cat diseases) and other fields. 

The company, after years of development, has established several specialized laboratories and SPF experimental animal bases, a comprehensive and systematic R&D verification platform and formed a professional technical service team to provide personalized customized services and one-stop solutions.

Qingdao Henderson Biotechnology Co., Ltd is willing to build a renowned product brand for all customers with high-quality products and professional services to keep a foothold in the market with its sound competitiveness.

Limited space only allows the introduction of major products. You are welcomed to contact Qingdao Henderson Biotechnology Co., Ltd and acquire trial samples if you need more information.

Qingdao Henderson Biotechnology Co., Ltd.

Official Website: http://www.qdhenderson.com/

Tel: 0532-84670782

E-mail: info@qdhenderson.com